Aptose Biosciences Inc (LTS:0UI8)
C$ 1.33 0 (0%) Market Cap: 10.54 Mil Enterprise Value: 98,000.00 PE Ratio: 0 PB Ratio: 0 GF Score: 31/100

Aptose Biosciences Inc Annual Shareholders Meeting Transcript

May 23, 2023 / 04:00PM GMT
Release Date Price: C$9.91
William G. Rice
Aptose Biosciences Inc. - Chairman, President, CEO & CAO

Good morning, all. I'd like to call to order this Annual and Special Meeting of the Shareholders of Aptose Biosciences Inc. I'm Dr. William Rice, Chairman of the Board of Directors, President and Chief Executive Officer of Aptose, and I'll be serving as the Chair of today's meeting.

Joining me today are other directors who have joined us either online or in person, including Dr. Denis Burger, our Lead Independent Director; Dr. Erich Platzer; Mr. Warren Whitehead; Ms. Carol Ashe, Dr. Bernd Seizinger and Dr. Mark Vincent. Other members of senior management joining us today are Mr. Fletcher Payne, Senior Vice President, Chief Financial Officer and Corporate Secretary; Dr. Rafael Bejar, Senior Vice President, Chief Medical Officer; and Dr. Philippe Ledru, Senior Vice President and Chief Commercial Officer.

It's my pleasure to welcome the shareholders and employees of Aptose and other invited guests to this meeting. This year, Aptose has opted for a hybrid format for the Annual Shareholders Meeting. By conducting

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot